Ernesto Schiffrin

Ernesto Schiffrin's AcademicInfluence.com Rankings

Ernesto Schiffrin

Philosophy

#2382

World Rank

#4092

Historical Rank

Logic

#551

World Rank

#1003

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Ernesto Schiffrin Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ernesto Luis Schiffrin is an Argentinian-Canadian physician and researcher specialized in cardiovascular diseases. Schiffrin is a distinguished James McGill Professor of Medicine at the Department of Medicine, McGill University . Canada Research Chair in Hypertension and Vascular Research at the Lady Davis Institute, and Physician-in-Chief at Jewish General Hospital.

(See a Problem?)

Ernesto Schiffrin's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. (2010) (2247)
Chronic Kidney Disease: Effects on the Cardiovascular System (2007) (1409)
Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association. (2015) (947)
Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. (2000) (942)
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. (2014) (923)
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis (2001) (921)
Clinical Practice Guidelines for the Management of Hypertension in the Community (2014) (726)
Endothelial dysfunction : Mechanisms of hypertension: Cells, hormones, and the kidney (2004) (704)
Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. (2005) (650)
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013) (625)
Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. (2000) (621)
Reactive oxygen species in vascular biology: implications in hypertension (2004) (617)
Expression of a Functionally Active gp91phox-Containing Neutrophil-Type NAD(P)H Oxidase in Smooth Muscle Cells From Human Resistance Arteries: Regulation by Angiotensin II (2002) (607)
Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent Pathways (2007) (483)
Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. (2018) (473)
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. (2003) (461)
Structure and Mechanical Properties of Resistance Arteries in Hypertension: Role of Adhesion Molecules and Extracellular Matrix Determinants (2000) (447)
Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. (2016) (428)
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR (2001) (414)
Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus (2008) (408)
Endothelial dysfunction. (2004) (408)
Role of the renin-angiotensin system in vascular inflammation. (2008) (398)
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress (2002) (393)
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2010) (390)
Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II–Infused Rats: Role of Peroxisome Proliferator–Activated Receptor-&ggr; (2002) (378)
Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. (2003) (373)
T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury (2011) (368)
Inflammation in hypertension (2006) (366)
Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction (2004) (323)
Role of endothelin-1 in hypertension and vascular disease. (2001) (316)
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk. (2006) (306)
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. (2007) (304)
Aldosterone: effects on the kidney and cardiovascular system (2010) (303)
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. (2004) (303)
Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension (2001) (302)
Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy. (1994) (293)
Reduced Vascular Remodeling, Endothelial Dysfunction, and Oxidative Stress in Resistance Arteries of Angiotensin II–Infused Macrophage Colony-Stimulating Factor–Deficient Mice: Evidence for a Role in Inflammation in Angiotensin-Induced Vascular Injury (2005) (285)
Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. (1993) (285)
c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells (2003) (281)
Vascular endothelin in hypertension. (2005) (278)
Effects of Aldosterone on the Vasculature (2006) (269)
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. (2017) (264)
Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways (2001) (262)
Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. (1984) (260)
Hypertension and COVID-19 (2020) (258)
Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. (1994) (257)
From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. (2004) (256)
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2012) (255)
Endothelin: potential role in hypertension and vascular hypertrophy. (1995) (253)
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice (2004) (252)
Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling (2003) (248)
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells (2007) (244)
Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src (2005) (241)
Role of endothelin-1 in hypertension (1999) (240)
Redox‐dependent signalling by angiotensin II and vascular remodelling in hypertension (2003) (239)
Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition. (1999) (231)
PPARα Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation (2002) (229)
Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. (2011) (218)
Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. (1999) (217)
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome (2009) (216)
Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells (2004) (209)
Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. (2002) (207)
Plasma endothelin in human essential hypertension. (1991) (205)
Vascular biology of endothelin. (1998) (204)
Vascular Remodeling in Hypertension: Mechanisms and Treatment (2012) (203)
Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. (1999) (201)
Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. (1985) (201)
T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury (2012) (199)
Docosahexaenoic Acid, a Peroxisome Proliferator–Activated Receptor-&agr; Ligand, Induces Apoptosis in Vascular Smooth Muscle Cells by Stimulation of p38 Mitogen-Activated Protein Kinase (2000) (199)
Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. (2020) (198)
Effect of Peroxisome Proliferator–Activated Receptor-&agr; and -&ggr; Activators on Vascular Remodeling in Endothelin-Dependent Hypertension (2003) (197)
Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. (1995) (192)
Structure and function of resistance arteries of hypertensive patients treated with a p-blocker or a calcium channel antagonist (1996) (192)
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2014) (189)
Vascular inflammation: a role in vascular disease in hypertension? (2003) (186)
Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. (2001) (182)
Enhanced expression of endothelin‐1 gene in resistance arteries in severe human essential hypertension (1997) (182)
Radioautographic localization of specific binding sites for blood-borne angiotensin II in the rat brain (1980) (180)
Reactivity of small blood vessels in hypertension: relation with structural changes. State of the art lecture. (1992) (176)
Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. (1993) (174)
PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. (2004) (173)
Vascular stiffening and arterial compliance. Implications for systolic blood pressure. (2004) (172)
Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR. (1999) (171)
Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients (2008) (170)
Beyond blood pressure: the endothelium and atherosclerosis progression. (2002) (168)
p47phox Associates With the Cytoskeleton Through Cortactin in Human Vascular Smooth Muscle Cells: Role in NAD(P)H Oxidase Regulation by Angiotensin II (2005) (167)
Immune mechanisms in hypertension and vascular injury. (2014) (162)
Aldosterone and Angiotensin II Synergistically Stimulate Migration in Vascular Smooth Muscle Cells Through c-Src–Regulated Redox-Sensitive RhoA Pathways (2008) (162)
Role of endothelin-1 in clinical hypertension: 20 years on. (2008) (161)
The angiotensin II type 2 receptor in cardiovascular disease (2010) (161)
Role of endothelin in human hypertension. (2003) (160)
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013) (159)
Myocardial Fibrosis in DOCA-Salt Hypertensive Rats: Effect of Endothelin ETA Receptor Antagonism (2000) (157)
Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats (2012) (155)
Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. (2006) (154)
Fibrosis, Matrix Metalloproteinases, and Inflammation in the Heart of DOCA-Salt Hypertensive Rats: Role of ETA Receptors (2002) (154)
Immune Mechanisms in Hypertension (2011) (152)
Identification of a biologically active circulating form of rat atrial natriuretic factor. (1985) (152)
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy. (2008) (151)
ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension (2003) (150)
Differential Calcium Regulation by Hydrogen Peroxide and Superoxide in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats (2004) (146)
The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2007) (145)
Peroxisome Proliferator-Activated Receptor-&agr; and Receptor-&ggr; Activators Prevent Cardiac Fibrosis in Mineralocorticoid-Dependent Hypertension (2003) (145)
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. (2011) (142)
Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. (1999) (142)
Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. (1995) (141)
Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. (2009) (140)
Vascular Actions of Aldosterone (2012) (140)
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. (2009) (139)
Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence (2016) (138)
Cyclic GMP as mediator and biological marker of atrial natriuretic factor. (1986) (138)
Correlation of endothelial function in large and small arteries in human essential hypertension. (2001) (137)
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy. (2006) (135)
Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. (1995) (135)
Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. (2013) (134)
Vascular and cardiac benefits of angiotensin receptor blockers. (2002) (134)
Vascular Mechanisms in the Pathogenesis of Stroke (2011) (133)
Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system. (2004) (133)
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function (2002) (132)
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases. (1999) (131)
Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive Patients (2007) (129)
Role of extracellular signal-regulated kinases in angiotensin II-stimulated contraction of smooth muscle cells from human resistance arteries. (1999) (128)
Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. (1995) (124)
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. (2002) (123)
ETA Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Remodeling in Aldosterone-Infused Rats (2001) (123)
Effect of aldosterone on vascular angiotensin II receptors in the rat. (1985) (122)
Immune regulation and vascular inflammation in genetic hypertension. (2010) (120)
Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Receptor regulation and intracellular Ca2+ modulation. (1996) (119)
A Critical Review of the Role of Endothelial Factors in the Pathogenesis of Hypertension (2001) (119)
Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. (1992) (115)
Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation. (2003) (115)
Vascular and Adrenal Receptors for Atrial Natriuretic Factor in the Rat (1985) (114)
T lymphocytes: a role in hypertension? (2010) (114)
Peroxisome proliferator-activated receptors and cardiovascular remodeling. (2005) (113)
Redox-Sensitive Signaling by Angiotensin II Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase SHP-2 in Vascular Smooth Muscle Cells From SHR (2008) (113)
Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive Treatment (2004) (112)
Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats (2004) (112)
Src Is an Important Mediator of Extracellular Signal–Regulated Kinase 1/2–Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive Patients (2001) (112)
Effect of atrial natriuretic factor (ANF)-related peptides on aldosterone secretion by adrenal glomerulosa cells: critical role of the intramolecular disulphide bond. (1984) (111)
Structural and Functional Alterations of Subcutaneous Small Resistance Arteries in Severe Human Obesity (2010) (110)
Effects of enalapril and amlodipine on small‐artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats (1998) (110)
The immune system: role in hypertension. (2013) (109)
In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. (1999) (107)
Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. (2008) (106)
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk. (2010) (106)
How to assess vascular remodelling in small and medium‐sized muscular arteries in humans (1997) (105)
Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice. (2007) (104)
Oxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies (2012) (104)
Endothelin and endothelin antagonists in hypertension (1998) (104)
Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. (1997) (103)
Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells (2001) (103)
Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus (2004) (102)
New insights on signaling cascades induced by cross-talk between angiotensin II and aldosterone (2008) (102)
Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. (1998) (101)
Combined Angiotensin II Type 1 and Type 2 Receptor Blockade on Vascular Remodeling and Matrix Metalloproteinases in Resistance Arteries (2005) (101)
Increased Angiotensin II-Mediated Src Signaling via Epidermal Growth Factor Receptor Transactivation Is Associated With Decreased C-Terminal Src Kinase Activity in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats (2002) (100)
Effect of angiotensin II and deoxycorticosterone infusion on vascular angiotensin II receptors in rats. (1984) (100)
PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. (2002) (99)
Effects of endothelin on resistance arteries of DOCA-salt hypertensive rats. (1992) (99)
Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. (1995) (98)
Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin‐1 (1994) (98)
Angiotensin Receptor Blocker Added to Previous Antihypertensive Agents on Arteries of Diabetic Hypertensive Patients (2006) (98)
Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. (1988) (97)
Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. (1998) (97)
c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats (2005) (97)
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support. (2006) (95)
Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats (2005) (93)
The Role of Aldosterone in the Metabolic Syndrome (2011) (91)
Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR. (1997) (91)
Clinical significance of endothelin in cardiovascular disease (1997) (91)
Endothelin-1 Overexpression Exacerbates Atherosclerosis and Induces Aortic Aneurysms in Apolipoprotein E Knockout Mice (2013) (90)
Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. (1996) (89)
p38 MAP Kinase Regulates Vascular Smooth Muscle Cell Collagen Synthesis by Angiotensin II in SHR But Not in WKY (2001) (89)
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis (2012) (89)
Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. (2005) (88)
Antioxidants in hypertension and cardiovascular disease. (2010) (87)
Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. (2002) (87)
Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. (1993) (85)
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy. (2005) (85)
Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a Receptors (2009) (85)
Effect of Hyperhomocystinemia and Hypertension on Endothelial Function in Methylenetetrahydrofolate Reductase–Deficient Mice (2003) (85)
Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats. (1996) (84)
Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. (2005) (84)
Role of immune cells in hypertension (2018) (84)
The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. (2005) (84)
Increased Expression of Peroxisome Proliferator-Activated Receptor-&agr; and -&ggr; in Blood Vessels of Spontaneously Hypertensive Rats (2001) (83)
Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. (1996) (83)
&ggr;&dgr; T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury (2017) (83)
Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. (1993) (82)
Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar–Kyoto rats and spontaneously hypertensive rats (2001) (80)
Plasma atrial natriuretic factor concentrations in essential and renovascular hypertension. (1987) (80)
Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension. (1993) (80)
In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. (1995) (80)
Oxidative stress, nitric oxide synthase, and superoxide dismutase: a matter of imbalance underlies endothelial dysfunction in the human coronary circulation. (2008) (79)
Disappearance of atrial natriuretic factor from circulation in the rat (1986) (79)
Antihypertensive effect of an endothelin receptor antagonist in DOCA‐salt spontaneously hypertensive rats (1995) (78)
Long-Term Effects of 4 Popular Diets on Weight Loss and Cardiovascular Risk Factors: A Systematic Review of Randomized Controlled Trials (2014) (78)
Apoptosis in aorta of deoxycorticosterone acetate‐salt hypertensive rats: effect of endothelin receptor antagonism (1997) (77)
Endothelin in hypertension: an update (2012) (77)
Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. (1992) (77)
Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells (2011) (76)
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk. (2009) (75)
Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. (1995) (75)
Dual opposing roles of adaptive immunity in hypertension. (2014) (74)
Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. (1997) (73)
Reduction of resistance artery stiffness by treatment with the AT1-receptor antagonist losartan in essential hypertension (2000) (72)
Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses (2016) (71)
Rat brain natriuretic peptide is localized in atrial granules and released into the circulation. (1992) (71)
Treatment of Arterial Remodeling in Essential Hypertension (2013) (70)
Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer (2012) (69)
Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase (2006) (69)
State-of-the-Art lecture. Role of endothelin-1 in hypertension. (1999) (68)
Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats. (2000) (68)
Inhibition of mitogen-activated protein/extracellular signal-regulated kinase improves endothelial function and attenuates Ang II-induced contractility of mesenteric resistance arteries from spontaneously hypertensive rats (2002) (67)
Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. (2001) (67)
Effect of magnesium on vascular tone and reactivity in pressurized mesenteric resistance arteries from spontaneously hypertensive rats. (1997) (67)
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. (2004) (66)
Endothelin-stimulated secretion of natriuretic peptides by rat atrial myocytes is mediated by endothelin A receptors. (1994) (65)
Role of Ca2+ in response of adrenal glomerulosa cells to angiotensin II, ACTH, K+, and ouabain. (1981) (64)
Vascular remodeling. (1996) (64)
Decreased in vitro responses to vasoconstrictors during gestation in normotensive and spontaneously hypertensive rats. (1987) (64)
Vascular and cardiac overexpression of endothelin‐1 gene in one‐kidney, one clip Goldblatt hypertensive rats but only in the late phase of two‐kidney one clip Goldblatt hypertension (1996) (63)
The endothelium and control of blood vessel function in health and disease. (1994) (63)
Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways. (1997) (63)
Aldosterone, Inflammation, Immune System, and Hypertension (2020) (63)
Role of mineralocorticoid receptor antagonists in cardiovascular disease. (2015) (63)
The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy. (2002) (62)
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action (2008) (62)
Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. (1997) (61)
Regulation of Plasma Endothelin by Salt in Salt-Sensitive Hypertension (2001) (61)
Multiple actions of angiotensin II in hypertension (2003) (61)
Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model. (2011) (61)
Effect of AT1 receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension (2002) (60)
Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. (1993) (60)
Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. (1996) (60)
PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1. (2005) (60)
Vascular inflammation in absence of blood pressure elevation in transgenic murine model overexpressing endothelin-1 in endothelial cells (2008) (59)
Peroxisome Proliferator–Activated Receptor &ggr; Regulates Angiotensin II–Stimulated Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Blood Vessels In Vivo (2006) (59)
Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. (2020) (59)
Time course and localization of endothelin-1 gene expression in a model of renal disease progression. (1997) (58)
Reversal of vascular hypertrophy in hypertensive patients through blockade of angiotensin II receptors. (2008) (57)
“Small Blood Vessels: Big Health Problems?”: Scientific Recommendations of the National Institutes of Health Workshop (2016) (57)
Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Angiotensin II–Induced Inflammation and Hypertension: Regulation of Oxidative Stress (2011) (57)
Aldosterone induces arterial stiffness in absence of oxidative stress and endothelial dysfunction (2009) (57)
Endothelin vascular receptors and responses in deoxycorticosterone acetate-salt hypertensive rats. (1992) (56)
Molecular Analysis of Human Prorenin Prosegment Variants in Vitro and in Vivo(*) (1995) (56)
Angiotensin II and Vasopressin Modulate Intracellular Free Magnesium in Vascular Smooth Muscle Cells through Na+-dependent Protein Kinase C Pathways* (1996) (56)
Aldosterone: A risk factor for vascular disease (2003) (55)
Transient Neonatal High Oxygen Exposure Leads to Early Adult Cardiac Dysfunction, Remodeling, and Activation of the Renin–Angiotensin System (2014) (55)
Central Actions and Brain Receptor Binding of Angiotensin II: Influence of Sodium Intake (1980) (55)
The New ACC/AHA Hypertension Guidelines for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. (2018) (55)
Endothelin receptor subtypes in resistance arteries from humans and rats. (1995) (54)
Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism (2003) (53)
Decreased density of vascular receptors for atrial natriuretic peptide in DOCA-salt hypertensive rats. (1987) (53)
ETA Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA–Salt Rats (2004) (53)
Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice (2007) (53)
Role of calcium influx and intracellular calcium stores in angiotensin II‐mediated calcium hyper‐responsiveness in smooth muscle from spontaneously hypertensive rats (1997) (53)
Effect of ACE/NEP inhibition on cardiac and vascular collagen in stroke-prone spontaneously hypertensive rats. (2001) (52)
Receptors for atrial natriuretic factor in cultured vascular smooth muscle cells. (1986) (52)
Vascular angiotensin II receptors in SHR. (1984) (51)
Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. (2011) (51)
Activation of the Na(+)-H+ exchanger modulates angiotensin II-stimulated Na(+)-dependent Mg2+ transport in vascular smooth muscle cells in genetic hypertension. (1999) (51)
Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy? (2001) (51)
Endothelin A Receptor Blockade Decreases Expression of Growth Factors and Collagen and Improves Matrix Metalloproteinase-2 Activity in Kidneys from Stroke-Prone Spontaneously Hypertensive Rats (2002) (50)
Mechanism of captopril-induced drinking. (1982) (50)
Angiotensin II Blockade Limits Tubular Protein Overreabsorption and the Consequent Upregulation of Endothelin 1 Gene in Experimental Membranous Nephropathy (1998) (50)
Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR. (2011) (50)
Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation? (2003) (50)
Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury (2017) (50)
Tyrosine kinase signaling pathways modulate angiotensin II-induced calcium ([Ca2+]i) transients in vascular smooth muscle cells. (1996) (49)
Endothelin-1, but not Ang II, Activates MAP Kinases Through c-Src–Independent Ras-Raf–Dependent Pathways in Vascular Smooth Muscle Cells (2007) (49)
Endothelin-1 attenuates omega3 fatty acid-induced apoptosis by inhibition of caspase 3. (2000) (48)
Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II (2004) (48)
Vascular Angiotensin II Receptors in Renal and DOCA‐Salt Hypertensive Rats (1983) (48)
Innate Immunity in Hypertension (2014) (47)
Cytosolic calcium changes induced by angiotensin II in neonatal rat atrial and ventricular cardiomyocytes are mediated via angiotensin II subtype 1 receptors. (1996) (47)
Insulin Attenuates Agonist‐Evoked Calcium Transients in Vascular Smooth Muscle Cells (1994) (47)
Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats. (1990) (45)
Assessment and pathophysiology of microvascular disease: recent progress and clinical implications (2020) (45)
Intracellular Ca2+ modulation by angiotensin II and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. (1996) (45)
Mitogen-activated protein kinase activation by hydrogen peroxide is mediated through tyrosine kinase-dependent, protein kinase C-independent pathways in vascular smooth muscle cells: upregulation in spontaneously hypertensive rats (2005) (45)
Modulation of Ca2+ transients in neonatal and adult rat cardiomyocytes by angiotensin II and endothelin-1. (1996) (44)
Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. (1996) (44)
Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium. (2011) (44)
Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension. (1999) (44)
Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats. (1998) (44)
Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats (1995) (44)
Prevalence of Diabetes and Hypertension and Their Associated Risks for Poor Outcomes in Covid-19 Patients (2020) (43)
The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension (1993) (43)
Partial characterization and solubilization of receptors for atrial natriuretic factor in rat glomeruli. (1985) (43)
Pathophysiology of smooth muscle in hypertension. (1995) (43)
Endothelin-1 Overexpression Exaggerates Diabetes-Induced Endothelial Dysfunction by Altering Oxidative Stress. (2016) (42)
Inhibition of the renin angiotensin system: Implications for the endothelium (2006) (42)
Blood Pressure Control and Benefits of Antihypertensive Therapy: Does It Make a Difference Which Agents We Use? (2001) (41)
Brain receptor binding and central actions of angiotensin analogs in rats. (1981) (41)
The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. (2006) (41)
Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice (2010) (41)
Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. (2002) (41)
The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. (2007) (41)
Reduction of C-reactive protein and the use of anti-hypertensives (2007) (40)
Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension. (2002) (40)
The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification. (2002) (40)
Effect of chronic ETA‐selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats (1997) (40)
Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats. (1996) (40)
Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. (1996) (40)
Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease. (2013) (40)
Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats (2004) (40)
Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors (2016) (39)
Glomerular ANF receptor regulation during changes in sodium and water metabolism. (1988) (38)
Cyclic GMP Inhibits a Pharmacologically Distinct Na+/H+ Exchanger Variant in Cultured Rat Astrocytes via an Extracellular Site of Action (1997) (38)
Atrial natriuretic factor: radioimmunoassay and effects on adrenal and pituitary glands. (1986) (38)
Vascular remodeling and endothelial function in hypertensive patients: effects of antihypertensive therapy. (1998) (37)
Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats (2005) (37)
Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways. (1997) (37)
Role of calcium in effects of atrial natriuretic peptide on aldosterone production in adrenal glomerulosa cells. (1987) (37)
Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. (1997) (37)
Monocyte Derivatives Promote Angiogenesis and Myocyte Survival in a Model of Myocardial Infarction (2010) (37)
Endothelin: role in experimental hypertension. (2000) (37)
Three-Month Endothelial Human Endothelin-1 Overexpression Causes Blood Pressure Elevation and Vascular and Kidney Injury (2018) (37)
Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats. (1999) (37)
Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor. (1996) (37)
Effect of antihypertensive treatment on small artery remodeling in hypertension. (2003) (37)
Endocrine Conditions and COVID-19 (2020) (36)
Hypertension in Canada: Past, Present, and Future. (2016) (36)
Primary aldosteronism: a common cause of resistant hypertension (2017) (36)
Platelet Binding Sites for Atrial Natriuretic Factor in Humans: Characterization and Effects of Sodium Intake (1986) (36)
Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats. (1998) (35)
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. (2005) (35)
Blood pressure and small arteries in DOCA-salt-treated genetically AVP-deficient rats: role of endothelin. (1999) (35)
Autoradiographic visualization of the natriuretic peptide receptor-B in rat tissues (1992) (35)
Reactive oxygen species and hypertension: a complex association. (2008) (35)
Effect of magnesium on calcium responses to vasopressin in vascular smooth muscle cells of spontaneously hypertensive rats. (1998) (34)
Tissue Targeting of Angiotensin Peptides* (1997) (34)
Role of T Regulatory Lymphocytes in the Pathogenesis of High-Fructose Diet–Induced Metabolic Syndrome (2013) (34)
Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism. (1999) (34)
Reduced Macrophage-Dependent Inflammation Improves Endothelin-1–Induced Vascular Injury (2013) (34)
Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP (2008) (34)
A Call to Regulate Manufacture and Marketing of Blood Pressure Devices and Cuffs: A Position Statement From the World Hypertension League, International Society of Hypertension and Supporting Hypertension Organizations (2016) (34)
The Protective Effects of Angiotensin II Blockade with Olmesartan Medoxomil on Resistance Vessel Remodeling (The VIOS study) (2006) (34)
Effects of antihypertensive therapy on hypertensive vascular disease (2000) (34)
Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries. (2000) (33)
Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats. (1995) (33)
High Blood Pressure 2016: Why Prevention and Control Are Urgent and Important. The World Hypertension League, International Society of Hypertension, World Stroke Organization, International Diabetes Foundation, International Council of Cardiovascular Prevention and Rehabilitation, International Soci (2016) (33)
Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a Model of Menopause-Associated Hypertension (2003) (33)
Endothelin receptors mediating vasoconstriction in rat pressurized small arteries. (1996) (32)
High Systolic Blood Pressure at Hospital Admission Is an Important Risk Factor in Models Predicting Outcome of COVID-19 Patients (2021) (32)
Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade. (2003) (32)
Induction of Cardiac Angiogenesis Requires Killer Cell Lectin-Like Receptor 1 and α4β7 Integrin Expression by NK Cells (2010) (32)
Effect of Antihypertensive Treatment on Response to Endothelin of Resistance Arteries of Hypertensive Rats (1993) (32)
Synergistic vascular protective effects of combined low doses of PPARα and PPARγ activators in angiotensin II‐induced hypertension in rats (2007) (32)
How Structure, Mechanics, and Function of the Vasculature Contribute to Blood Pressure Elevation in Hypertension. (2020) (32)
Mechanical properties of mesenteric resistance arteries from Dahl salt‐resistant and salt‐sensitive rats: role of endothelin‐1 (1998) (32)
Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan. (1995) (31)
3H-vasopressin binding to the rat mesenteric artery. (1983) (31)
SPRINT Proves that Lower Is Better for Nondiabetic High-Risk Patients, but at a Price. (2016) (31)
Vasopressin responses and receptors in the mesenteric vasculature of estrogen-treated rats. (1986) (31)
Vascular Effects of Antihypertensive Drug Therapy (2010) (31)
Effect of antihypertensive treatment and Nω -nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats (1996) (30)
Aberrant adenylyl cyclase/cAMP signal transduction and G protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy. (1996) (30)
Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers. (2002) (30)
Morphological and functional alterations of mesenteric small resistance arteries in early renal hypertension in rats. (1991) (30)
Extrarenal angiotensin-forming enzymes. (1983) (30)
Endothelin-1 gene expression in blood vessels and kidney of spontaneously hypertensive rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats. (1998) (30)
Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. (1994) (30)
Small Artery Remodeling in Hypertension: Can It Be Corrected? (2001) (30)
Effects of Recombinant Human Erythropoietin on Resistance Artery Endothelial Function in Stage 4 Chronic Kidney Disease (2013) (29)
The World Hypertension League and International Society of Hypertension Call on Governments, Nongovernmental Organizations, and the Food Industry to Work to Reduce Dietary Sodium (2014) (29)
Inducible Human Endothelin-1 Overexpression in Endothelium Raises Blood Pressure via Endothelin Type A Receptors (2015) (29)
Mechanism of Captopril-Induced Renin Release in Conscious Rats (1981) (29)
Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. (1995) (29)
Mechanisms of remodelling of small arteries, antihypertensive therapy and the immune system in hypertension. (2015) (28)
Role of endothelins in animal models of hypertension: focus on cardiovascular protection. (2003) (28)
Inducible nitric oxide synthase in vascular smooth muscle cells from prehypertensive spontaneously hypertensive rats. (1996) (28)
Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats. (1993) (28)
Involvement of Oxidative Stress in the Profibrotic Action of Aldosterone Interaction With the Renin-Angiotensin System (2004) (28)
Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy (2011) (28)
Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats (2002) (27)
Global Impact of the 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective From Canada. (2018) (27)
PPAR Activation: A New Target for the Treatment of Hypertension (2007) (27)
Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels. (1987) (27)
Calcium, Phosphoinositide, and 1,2‐Diacylglycerol Responses of Blood Vessels of Deoxycorticosterone Acetate–Salt Hypertensive Rats to Endothelin‐1 (1992) (27)
Vascular structure in NG-nitro-L-arginine methyl ester-induced hypertension: methodological considerations for studies of small arteries in hypertension. (1995) (27)
Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells. (2005) (27)
Inflammation, immunity and development of essential hypertension. (2014) (26)
Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. (2011) (26)
Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats. (1988) (26)
Control rates of hypertension in North America. (2010) (26)
Erythropoietin-induced hypertension and vascular injury in mice overexpressing human endothelin-1: exercise attenuated hypertension, oxidative stress, inflammation and immune response (2014) (26)
Circulatory therapeutics: use of antihypertensive agents and their effects on the vasculature (2010) (26)
Effect of chronic treatment with two different ETA selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats (1998) (25)
[Prospective study of the effects of an angiotensin converting enzyme inhibitor and a beta blockader on the structure and function of resistant arteries in mild essential hypertension]. (1994) (25)
Renal glomerular atrial natriuretic factor receptors in one-kidney, one clip rats. (1988) (25)
Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents. (2012) (25)
Endothelin: role in hypertension. (1998) (25)
Intracellular signal transduction for vasoactive peptides in hypertension. (1994) (25)
Immune modulation of resistance artery remodelling. (2012) (25)
Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade. (2007) (24)
Blunted inhibition by insulin of agonist‐stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients (1994) (24)
Receptors for Arg8-vasopressin, angiotensin II, and atrial natriuretic peptide in the mesenteric vasculature of pregnant rats. (1991) (24)
Innate and Innate-Like Immune System in Hypertension and Vascular Injury (2019) (24)
The many targets of aldosterone. (2004) (24)
Endothelin in hypertension. (1995) (24)
Resistance arteries as endpoints in hypertension. (1997) (24)
Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells. (1991) (24)
Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats. (1997) (23)
Activation of the Cardiac Renin-Angiotensin System in High Oxygen-Exposed Newborn Rats: Angiotensin Receptor Blockade Prevents the Developmental Programming of Cardiac Dysfunction. (2016) (23)
Role of Angiotensin Type-1 and Angiotensin Type-2 Receptors in the Expression of Vascular Integrins in Angiotensin II–Infused Rats (2006) (23)
Insulin-induced Ca2+ transport is altered in vascular smooth muscle cells of spontaneously hypertensive rats. (1994) (22)
Is It Time to Reappraise Blood Pressure Thresholds and Targets? A Statement From the International Society of Hypertension-A Global Perspective. (2016) (22)
Orthostatic Hypotension: A Posture‐Induced Hyperdopaminergic State (1985) (22)
Atrial Natriuretic Peptide Inhibits the Stimulation of Aldosterone Secretion by ACTH in Vitro and in Vivo (1986) (22)
Recommendations for Intensive Blood Pressure Lowering in High-Risk Patients, the Canadian Viewpoint. (2016) (22)
Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia. (2009) (22)
Atrial natriuretic peptide inhibits the effect of endogenous angiotensin II on plasma aldosterone in conscious sodium-depleted rats. (1987) (22)
Platelet binding sites and plasma concentration of atrial natriuretic peptide in patients with essential hypertension. (1988) (21)
Racial disparities in cardiovascular risk factors among diagnosed hypertensive subjects. (2011) (21)
The vascular phenotypes in hypertension: Relation with the natural history of hypertension. (2007) (21)
Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats. (2000) (21)
Significance of recently identified peptides in hypertension: endothelin, natriuretic peptides, adrenomedullin, leptin. (2004) (21)
Effect of short-term treatment of SHR with the novel calcium channel antagonist mibefradil on function of small arteries. (1997) (21)
Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH. (1983) (21)
Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients? (2005) (21)
Molecular Mechanisms in Hypertension (2006) (21)
Downregulation of glomerular and vascular atrial natriuretic factor receptor subtypes by angiotensin II. (1991) (20)
Mesenteric vascular smooth muscle cells from SHR display increased Ca 2+ responses to angiotensin II but not to endothelin-1 (1994) (20)
Relative roles of sodium and calcium ions in the steroidogenic response of isolated rate adrenal glomerulosa cells. (1982) (20)
The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference (2000) (20)
Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities (2012) (20)
The International Society of Hypertension and World Hypertension League call on governments, nongovernmental organizations and the food industry to work to reduce dietary sodium. (2014) (20)
Enhanced Expression of Endothelin‐1 Gene May Cause Blood Pressure‐Independent Vascular Hypertrophy (1995) (19)
Endothelin influences pHi of human platelets through protein kinase C mediated pathways. (1995) (19)
miR-431-5p Knockdown Protects Against Angiotensin II–Induced Hypertension and Vascular Injury (2019) (19)
Vascular protection with newer antihypertensive agents. (1998) (19)
Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats. (2000) (18)
Differential effects of vasopressin and endothelin‐1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats (1996) (18)
Atrial natriuretic factor: specific binding to renal glomeruli during the development of two-kidney, one clip hypertension in the rat. (1988) (18)
Peroxisome proliferator-activated receptors and the vascular system: beyond their metabolic effects. (2008) (18)
Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. (1998) (18)
Atrial Natriuretic Factor Receptor Subtypes in the Rat Central Nervous System (1991) (18)
Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats. (1984) (18)
Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: role of oxidative stress and PRMT-1. (2009) (18)
Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. (2003) (17)
Vascular smooth muscle cell peroxisome proliferator-activated receptor &ggr; protects against endothelin-1-induced oxidative stress and inflammation (2017) (17)
Remodeling of resistance arteries in human hypertension: effects of cilazapril, an angiotensin-I-converting enzyme inhibitor. (1995) (17)
Effect of dietary sodium on plasma concentration of immunoreactive atrial natriuretic factor in normal humans. (1986) (17)
Effects of Antihypertensive Treatment on Vascular Remodeling in Essential Hypertensive Patients (1994) (17)
Vascular smooth muscle growth and extracellular matrix deposition: is there a role for the sympathetic nervous system? (2002) (17)
The flame that lights the fire: oxidative stress, inflammation, and renal damage in angiotensin II-induced hypertension. (2008) (17)
Effects of PPAR-γ Knock-down and Hyperglycemia on Insulin Signaling in Vascular Smooth Muscle Cells From Hypertensive Rats (2007) (16)
Antiproliferative effect of L-NAME on rat vascular smooth muscle cells. (2000) (16)
Inhibitory effects of PPAR-gamma on endothelin-1-induced inflammatory pathways in vascular smooth muscle cells from normotensive and hypertensive rats. (2007) (16)
Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats. (2007) (16)
Long-term effects of the PPAR gamma activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats. (2004) (16)
Biological action and binding sites for vasopressin on the mesenteric artery from normal and sodium-depleted rats. (1984) (16)
Vasopressin receptors and inositol trisphosphate production in blood vessels of spontaneously hypertensive rats. (1989) (16)
What Is the Ideal Blood Pressure Goal for Patients with Diabetes Mellitus and Nephropathy? (2012) (15)
ENDOTHELIN‐1 GENE EXPRESSION AND VASCULAR HYPERTROPHY IN DOCA‐SALT HYPERTENSION COMPARED TO SPONTANEOUSLY HYPERTENSIVE RATS (1995) (15)
Renal Effects of Immersion in Essential Hypertension (1994) (15)
Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways (1999) (15)
2016 Dietary Salt Fact Sheet and Call to Action: The World Hypertension League, International Society of Hypertension, and the International Council of Cardiovascular Prevention and Rehabilitation (2016) (15)
Role of Interleukin-23/Interleukin-17 Axis in T-Cell Mediated Actions in Hypertension. (2020) (15)
Do We Need a New Definition of Hypertension After SPRINT? (2016) (15)
Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause. (2008) (15)
Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats: Role of AT1 Receptors (2001) (15)
Response by Caillon et al to Letter Regarding Article, "γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury". (2017) (15)
Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats. (1990) (15)
Blood Pressure Effects of Angiotensin II and Vasopressin in Conscious Pregnant Normotensive and Spontaneously Hypertensive Rats (1986) (14)
CD4+ Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II‐Induced Hypertension (2018) (14)
Endothelin–aldosterone interaction and proteinuria in low-renin hypertension (2004) (14)
The angiotensin-endothelin relationship: does it play a role in cardiovascular and renal pathophysiology? (2003) (14)
Glomerular Atrial Natriuretic Factor Receptors in Spontaneously Hypertensive Rats (1989) (14)
Circulating let-7g-5p and miR-191-5p are independent predictors of chronic kidney disease in hypertensive patients. (2020) (14)
Divergent regulation of atrial natriuretic factor receptors in high-output heart failure. (1992) (14)
Calcium dependence of effects of endothelin on rat mesenteric microvessels. (1991) (14)
Glomerular and Vascular Atrial Natriuretic Factor Receptors in Saralasin‐Sensitive and Resistant Two‐Kidney, One‐Clip Hypertensive Rats (1988) (14)
Hypertensive eye disease (2022) (13)
Expertise: no longer a sine qua non for guideline authors? (2017) (13)
Increased blood pressure, vascular inflammation, and endothelial dysfunction in androgen-deficient follitropin receptor knockout male mice. (2007) (13)
Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension (2006) (13)
Endothelin receptor subtypes in mesenteric vascular smooth muscle cells of spontaneously hypertensive rats. (1995) (13)
Pressor effect of tonin in anephric animals. (1981) (13)
Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers. (1988) (13)
Inhibition of the renin-angiotensin system for lowering coronary artery disease risk. (2013) (13)
A Novel and Simplified Method of Culture of Human Blood-Derived Early Endothelial Progenitor Cells for the Treatment of Ischemic Vascular Disease (2011) (13)
Improving Hypertension Outcome Measurement in Low- and Middle-Income Countries (2019) (13)
Vascular and Adrenal Binding Sites for Atrial Natriuretic Factor Effects of Sodium and Hypertension (1986) (13)
Does Endothelin-1 Raise or Lower Blood Pressure in Humans? (2018) (12)
Hypertension and COVID-19: Updates from the era of vaccines and variants (2021) (12)
Preservation of Endothelium-Dependent Relaxation in Atherosclerotic Mice with Endothelium-Restricted Endothelin-1 Overexpression (2013) (12)
Glomerular atrial natriuretic factor receptors during rehydration: plasma NH2- and COOH-terminal levels. (1988) (12)
Blunted attenuation of angiotensin II-mediated Ca2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats. (1995) (11)
Vasorelaxation and vascular binding sites for atrial natriuretic peptide in pregnant rats. (1988) (11)
Effects of Tonin, an Angiotensin II‐Forming Enzyme, on Vascular Smooth Muscle in the Normal Rabbit (1981) (11)
Hypertension in 2017: Novel mechanisms of hypertension and vascular dysfunction (2018) (11)
Hypertension: treatments, diabetes, and developing regions (2012) (11)
ENDOTHELIAL NO SYNTHASE UNCOUPLING AND PERIVASCULAR ADIPOSE OXIDATIVE STRESS AND INFLAMMATION CONTRIBUTE TO VASCULAR DYSFUNCTION IN A RODENT MODEL OF METABOLIC SYNDROME (2009) (11)
Vascular receptors for angiotensin, vasopressin, and atrial natriuretic peptide in experimental hypertension. (1989) (11)
The heart as an endocrine gland. (1987) (11)
ETA AND ETB RECEPTORS ON VASCULAR SMOOTH MUSCLE CELLS FROM MESENTERIC VESSELS OF SPONTANEOUSLY HYPERTENSIVE RATS (1995) (11)
Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR. (1996) (11)
Immune mechanisms in hypertension: how do T-regulatory lymphocytes fit in? (2013) (11)
Basal and angiotensin II-induced cytosolic free calcium in adult rat cardiomyocytes and fibroblasts after volume overload. (1995) (10)
Calcium, magnesium, and oxidative stress in hyperaldosteronism. (2005) (10)
Some physiopathological aspects of atrial natriuretic factor. (1986) (10)
Solubilization and molecular characterization of the atrial natriuretic peptide (ANP) receptor in human platelets: comparison with ANP receptors in rat tissues. (1991) (10)
Expression of cell cycle proteins in blood vessels of angiotensin II-infused rats: role of AT(1) receptors. (2001) (10)
Reduction of Hypertension in One-Kidney One-Clip Rabbits by Immunization with Tonin (1979) (10)
Signal transduction in hypertension: Part II. (1993) (10)
Effect of a chronic infusion of atrial natriuretic factor on glomerular and vascular receptors in spontaneously hypertensive rats. (1989) (10)
The endothelium of resistance arteries: physiology and role in hypertension. (1996) (10)
Effects of monovalent and divalent cations and of guanine nucleotides on binding of vasopressin to the rat mesenteric vasculature. (1987) (10)
Vascular vasopressin receptors in renal hypertensive rats. (1988) (10)
Structure and function of small arteries of essential hypertensive patients following chronic treatment with once-a-day nifedipine. (1997) (9)
Progress in secondary prevention of stroke with PROGRESS (2002) (9)
Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension. (1985) (9)
Effect of antihypertensive therapy on small artery structure in hypertensive patients. (1995) (9)
Glomerular and vascular atrial natriuretic factor receptors in cardiomyopathic hamsters: correlation with the peptide biological effects. (1990) (9)
Renin-Angiotensin-Aldosterone System and Pathobiology of Hypertension (2009) (9)
Comparative biological activities of ANF (Arg 101-Tyr 126) and the synthetic form of circulating ANF (Ser 99-Tyr 126). (1986) (9)
Human and murine memory γδ T cells: Evidence for acquired immune memory in bacterial and viral infections and autoimmunity (2020) (9)
Role of protein kinase C in the anti-aggregatory effects of endothelin-1 on human platelets. (1995) (9)
Vascular Effects of Bradykinin and Sodium Nitroprusside During Pregnancy in the Rat (1989) (8)
SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension. (2004) (8)
Hypertension induced by brain grafts from fetal spontaneously hypertensive rats. (1994) (8)
Oxidative Stress in Arterial Hypertension: Oxidative Stress and Hypertension (2008) (8)
CXCL1-CXCR2 lead monocytes to the heart of the matter. (2018) (8)
Periodontitis and hypertension: causally linked by immune mechanisms. (2019) (8)
Hypertension Guidelines in the United States and Canada: Are We Getting Closer? (2018) (8)
Media-to-lumen ratio as predictor of renal abnormalities in hypertension: new findings, new questions. (2010) (8)
Novel drugs targeting hypertension: renin inhibitors and beyond. (2007) (8)
Activation of the Cardiac Renin–Angiotensin System in High Oxygen-Exposed Newborn RatsNovelty and Significance (2016) (8)
In vivo heterologous regulation of rat glomerular and vascular atrial natriuretic factor receptors by angiotensin II. (1990) (8)
International Society of Hypertension Low and Middle Income Countries Committee: Review of the goals of the Committee and of 5 years of ISH activities in low and middle income countries. (2010) (8)
Differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from spontaneously hypertensive rats (1996) (7)
Glomerular and vascular atrial natriuretic factor receptors in adrenalectomized rats. (1989) (7)
Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat. (1988) (7)
Heart Rate Reflex Responses during Gestation in Normotensive and Spontaneously Hypertensive Rats following Angiotensin II and Vasopressin (1987) (7)
Review: ACE inhibition or angiotensin receptor blockade: which should we use in diabetic patients? (2003) (7)
Immune System and Microvascular Remodeling in Humans (2022) (7)
New twist to the role of the renin-angiotensin system in heart failure: aldosterone upregulates renin-angiotensin system components in the brain. (2008) (7)
Modulation of Ca2+ Transients in Neonatal and Adult Rat Cardiomyocytes by Endothelin‐1 (1995) (7)
Low birth weight and insulin resistance: can capillary recruitment predict hypertension development? (2002) (7)
P2X7: An Untapped Target for the Management of Cardiovascular Disease. (2020) (6)
ENDOTHELIUM-RESTRICTED ENDOTHELIN-1 OVEREXPRESSION IN TYPE-1 DIABETES WORSENS ATHEROSCLEROSIS AND IMMUNE CELL INFILTRATION VIA NOX1. (2020) (6)
The Endothelin System (2012) (6)
PPAR- inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1 (2005) (6)
Resistant Hypertension: An Update. (2018) (6)
Hypertension Prevalence and Control: Impact of Method of Blood Pressure Measurement (2012) (6)
Vascular atrial natriuretic factor receptors in spontaneously hypertensive rats. (1992) (6)
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study. (2019) (6)
Activator Effects on Ang II – Induced Vascular Oxidative Stress and Inflammation (2002) (6)
PS 07-28 GAMMA/DELTA T CELLS MEDIATE ANGIOTENSIN II-INDUCED HYPERTENSION AND VASCULAR INJURY (2016) (6)
Ca2+ and Contractile Responses of Resistance Vessels of WKY Rats and SHR to Endothelin‐1 (1995) (6)
Ferrario and Schiffrin Aldosterone Antagonism in Cardiovascular Disease 207 (2014) (6)
Atrial natriuretic factor binding sites in rat area postrema: autoradiographic study. (1992) (5)
Renovascular Hypertension: To Stent or Not to Stent? (2014) (5)
P2X7 (2020) (5)
Regulation of ANG II and AVP receptors in isolated hepatocytes of pregnant rats. (1990) (5)
Treatment of non-insulin-dependent diabetic hypertensive patients with Ca2+ channel blockers is associated with increased platelet sensitivity to insulin. (1995) (5)
Atrial natriuretic factor in experimental and human hypertension. (1988) (5)
Specific binding of atrial natriuretic factor to renal glomeruli during day or night antiorthostatic suspension in the rat. (1988) (5)
Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation. (2010) (5)
ROLE OF ENDOTHELIUM IN MODULATION OF STRUCTURAL CHANGES OF SMALL ARTERIES IN HYPERTENSION : EFFECTS OF THERAPEUTIC INTERVENTION (1998) (5)
Endothelin-1 signaling is altered in cardiac cells from deoxycorticosterone acetate-salt hypertensive rats. (1998) (5)
Biology of Blood Vessels in Hypertension (1993) (5)
P-42: Vascular improvement with olmesartan medoxomil (2005) (5)
Effects of Tonin on the Adrenal Secretion in the Rat (1981) (4)
Signal transduction in hypertension: Part I. (1993) (4)
Effects Of Endothelin-1 On Intracellular Tetrahydrobiopterin Levels In Vascular Tissue (2018) (4)
Renal effects of immersion in essential hypertension. Carvedilol Study Group. (1994) (4)
CD 4 + Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II-Induced Hypertension (2018) (4)
Scoping review of COVID-19-related systematic reviews and meta-analyses: can we really have confidence in their results? (2021) (4)
Mechanical Stress and the Arterial Wall (2014) (4)
29 Prospective trial of effects of an angiotensin I‐converting enzyme inhibitor and a beta‐blocker on structure and function of resistance arteries in mild essential hypertension (1994) (4)
Endothelin, role in hypertension and vascular hypertrophy (1997) (4)
MEthods of ASsessing blood pressUre: identifying thReshold and target valuEs (MeasureBP): A Review & Study Protocol (2015) (4)
B1 Effect of AT1 angiotensin receptor blockade on structure and function of small arteries in SHR (1997) (4)
Src modulates Ang II-mediated Ca2+ signaling in human vascular smooth muscle cells (1999) (4)
Isolation of Immune Cells for Adoptive Transfer. (2017) (4)
Professor Alberto C. Taquini 1905-1998. (1998) (4)
On the circulating form of atrial natriuretic factor. (1985) (4)
Renal Denervation Therapy for Resistant Hypertension (2014) (4)
Clinical trials report (2004) (4)
Chronische Nierenerkrankungen und kardiovaskuläres System (2008) (4)
The Year in Clinical Hypertension From Other Pages. (2018) (4)
Inositol phosphate production in response to [Arg8]vasopressin, endothelin 1, and prostaglandin F2 alpha in rat aorta and mesenteric arteries. (1992) (4)
Integrin Expression by NK Cells Killer Cell Lectin-Like Receptor 1 and Induction of Cardiac Angiogenesis Requires (2010) (4)
Sex Differences in the Immune System in Relation to Hypertension and Vascular Disease. (2022) (4)
PPAR-inhibits ANG II-induced cell growth via SHIP 2 and 4 EBP 1 (2005) (4)
Tyrosine Kinase Inhibition Attenuates Vasopressin-induced Contraction of Mesenteric Resistance Arteries: Alterations in Spontaneously Hypertensive Rats (2002) (4)
Chronic Elevation of Endothelin-1 Alone May Not Be Sufficient to Impair Endothelium-Dependent Relaxation. (2019) (4)
Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in SHRSP (2000) (4)
Role of Prostaglandins, β-Adrenoceptors, and the Central Nervous System in the Control of Renin Release in Conscious Sodium-Depleted Rats (1980) (4)
Overproduction of endothelin-1 impairs glucose tolerance but does not promote visceral adipose tissue inflammation or limit metabolic adaptations to exercise. (2019) (4)
Cardiac microvascular changes in DOCA-salt hypertensive rats: effect of endothelin ETA receptor antagonism (1999) (3)
Vascular mineralocorticoid receptors regulate blood pressure effects on myogenic tone and role in aging. (2013) (3)
A New Look At the Mosaic Theory of Hypertension. (2020) (3)
Pharmacodynamic Effects of Bolus Administration of ANF in Normal Volunteers (1986) (3)
Expertise: No Longer a Sine Qua Non for Guideline Authors? (2017) (3)
Effects of tonin on the response to norepinephrine by the aortic strip of the hypertensive rat. (1981) (3)
Generation of a Mouse Model with Smooth Muscle Cell Specific Loss of the Expression of PPARγ. (2017) (3)
More evidence of cardiorenal protective effects of peroxisome proliferator-activated receptor activation. (2005) (3)
Effect of low normal and high normal sodium intake on hormonal and metabolic responses to ACTH, angiotensin II and an acute salt load in normal subjects. (1984) (3)
Angiotensin II and Inflammation (2007) (3)
1108-123 The effect of eplerenone on markers of cardiac fibrosis: Insights from EPHESUS (2004) (3)
The Pituitary and Hypertension (1984) (3)
Alpha 1-adrenergic receptors in the mesenteric vascular bed of renal and spontaneously hypertensive rats. (1984) (3)
Endothelin system: roles in hypertension (2013) (3)
[Chronic kidney disease and the cardiovascular system]. (2008) (3)
Atrial natriuretic factor (ANF) in experimental and human hypertension. (1987) (3)
An unusual cause of mineralocorticoid hypertension. (2014) (3)
What is the Connection Between Hypertension , Headache and Migraine ? (2006) (3)
Clinical relationships of cyclic GMP. (1994) (3)
Biochemical aspects of a new hormone: rat atrial natriuretic factor (rANF). (1985) (2)
Chromosome 2 Fragment Substitutions in Dahl Salt-Sensitive Rats and RNA Sequencing Identified Enpep and Hs2st1 as Vascular Inflammatory Modulators (2020) (2)
Endothelin in Hypertension: A Role in Vascular Hypertrophy? (1997) (2)
Guest Editor’s Letter (2001) (2)
P38 MAP Kinase Regulates Vascular Smooth Muscle Cell (VSMC) Collagen Synthesis by Ang II in Shr But not in Wky. (2000) (2)
Structure-Activity Relationships of Atrial Natriuretic Peptides (1987) (2)
Recombinant human erythropoietin alters subcutaneous resistance artery endothelial function through a mechanism involving oxidative stress and endothelin-1 in patients with stage 4 chronic kidney disease (2011) (2)
Clinical trials report. CHARM-Preserved Trial. (2004) (2)
In memoriam: Wolfgang Kiowski, M.D. (1949-2012)--pioneer in clinical endothelin research. (2014) (2)
Reactive Oxygen Species in Hypertension and Atherosclerosis 51 (2014) (2)
A Compendium on Hypertension: New Advances and Future Impact. (2021) (2)
Erratum to “Angiotensin II, Aldosterone, and Anti-Inflammatory Lymphocytes: Interplay and Therapeutic Opportunities” (2012) (2)
Optimum blood pressure target after lacunar stroke: con side of the argument. (2014) (2)
Angiotensin II-induced a steeper blood pressure elevation in IL-23 receptor-deficient mice: Role of interferon-γ-producing T cells (2022) (2)
61 ALDOSTERONE-INDUCED SMALL ARTERY ENDOTHELIAL DYSFUNCTION, INFLAMMATION AND OXIDATIVE STRESS REQUIRES A FUNCTIONAL ANGIOTENSIN TYPE 1A RECEPTOR (2012) (2)
Clinical trials report. CHARM-Alternative Trial. (2004) (2)
Erratum: Angiotensin II/AT2 receptor-induced vasodilation in SHRSP involves nitric oxide and cGMP-dependent protein kinase (Journal of Hypertension (2006) 24 (2417-2422)) (2007) (2)
Expression of Cell Cycle Proteins in Blood Vessels of Angiotensin II–Infused Rats (2001) (2)
Effects of tonin on vascular smooth muscle of the hypertensive rat and normal rabbit. (1980) (2)
A call to action to implement prescribing authority to pharmacists for hypertension management (2019) (2)
Clinical trials report. CHARM-Added Trial. (2004) (2)
Automated Detection and Diameter Estimation for Mouse Mesenteric Artery using Semantic Segmentation (2020) (2)
Eta Receptor Antagonist Prevents Blood Pressure Elevation and Vascular Hypertrophy of Resistance Arteries in Aldosterone-Infused Rats. (2000) (2)
Excellence Award in Hypertension Research Vascular Remodeling in Hypertension Mechanisms and Treatment (2012) (2)
Vascular receptors for atrial natriuretic peptide in hypertension. (1990) (2)
Endothelin in Hypertension and Vascular Hypertrophy: Experimental Studies (1995) (2)
Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED? (2020) (2)
Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium (2021) (2)
Endothelial function in large and small arteries is closely correlated in human hypertension (2000) (2)
Small Artery Remodeling Is the First Manifestation of Target Organ Damage in Mild Essential Hypertension. (2000) (2)
New blood pressure cut-offs, prevalence of hypertension and control, and mood disorders: are patients benefitting from lower cut-offs for defining hypertension? (2019) (2)
O-42: ANG II activates P38 MAP kinase and ERK1/2, but not JNK, in vascular smooth muscle cells from SHR (2001) (1)
Atrial natriuretic peptide interferes with calcium requirements in vascular tissues of the rat. (1988) (1)
Regulation of receptors for atrial natriuretic peptide in the rat and human (1988) (1)
Vascular Changes in the Microcirculation: Arterial Remodeling and Capillary Rarefaction (2015) (1)
Hypertensive vascular disease (2013) (1)
Cardiac-specific deficiency of 3-hydroxy-3-methylglutaryl coenzyme A lyase in mice causes cardiomyopathy and a distinct pattern of acyl-coenzyme A-related biomarkers. (2022) (1)
Role of vasopressin in vascular remodeling of DOCA-salt-treated brattleboro rats. (1999) (1)
Relative Roles of Sodium and Calcium Ions in the Steroidogenic Response of Isolated Rat Adrenal Glomerulosa Cells (1982) (1)
Pharmacodynamics of Infusions of ANF in Normotensive and Hypertensive Subjects (1986) (1)
Jacques de Champlain, Md, PhD, FAHA, 1938-2009. (2009) (1)
At1 Angiotensin Receptor Blockade and Angiotensin Converting Enzyme Inhibition: Effects on Vascular Remodeling and Endothelial Dysfunction in Shr (1998) (1)
LBPS 01-03 ENDOTHELIN-1 OVEREXPRESSION EXAGGERATES DIABETES-INDUCED ENDOTHELIAL DYSFUNCTION BY ALTERING OXIDATIVE STRESS BALANCE (2016) (1)
A039: Effect of carvedilol versus metoprolol treatment of stroke-prone SHR on endothelial function of resistance arteries (2000) (1)
Attenuated Development of Hypertension by Antioxidant Vitamins in Stroke-Prone Shr Is Associated with Increased Vascular Superoxide Dismutase Activity and Decreased Oxidative Stress. (2000) (1)
Rare cause of severe hypertension in a young woman. (2015) (1)
Abstract 299: Remodeling of Endothelial Function in Atherosclerotic Mice Overexpressing Endothelin-1 Restricted to Endothelium (2013) (1)
Insulin-Induced Ca 2 + Transport Is Altered in Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats (2005) (1)
Tempol, Vitamin C and Vitamin E Improve Endothelial Dysfunction, Regress Vascular Hypertrophy and Prevent Progression of Hypertension and Renal Dysfunction in Stroke-Prone Shr (2000) (1)
Hope gives reason for hope (2000) (1)
P-313: Effect of ETA receptor antagonist on hypertrophy and collagen deposition in heart and aorta in response to chronic aldosterone infusion (2001) (1)
Effects of Recombinant Human Erythropoietin on Resistance Artery Endothelial Function in Stage 4 Chronic Kidney Disease Role of Oxidative Stress and Endothelin-1 (2013) (1)
Compendium on Hypertension: The Microbiome, Inflammation and Oxidative Stress, the Sympathetic Nervous System and Treatment of Hypertension. (2020) (1)
I012: AT1 receptor activation of vascular smooth muscle cell ERK1/2 and p38 map kinase is differentially regulated in genetic hypertension (2000) (1)
OS 21-01 NOX1 OR NOX4 DELETION PREVENTS TYPE 1 DIABETES-INDUCED ENDOTHELIAL DYSFUNCTION (2016) (1)
A2935 microRNA profiling in peripheral blood mononuclear cells from hypertensive patients with or without chronic kidney disease (2018) (1)
Role of the pituitary in the effects of tonin on adrenal secretion of the rat. (1983) (1)
Abstract 45: Reduced Vascular Remodeling and Improved Endothelial Function in Transglutaminase 2 Knock-Out Mice Treated with Angiotensin II (2013) (1)
HOPE gives reason for hope. Heart Outcomes Prevention Evaluation. (2000) (1)
RESISTANCE ARTERIES IN TYPE 2 DIABETIC PATIENTS UNDER ANTIHYPERTENSIVE TREATMENT SHOW MARKED REMODELING.: P 460 (2004) (1)
Ang II type 2 receptor activates JNK/SAPK-dependent signaling pathways. (1999) (1)
Suppression of peroxisome proliferator-activated receptor-gamma activity by angiotensin II in vascular smooth muscle involves Bcr kinase: the fire that drowns the water. (2008) (1)
Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS (2022) (1)
PLASMA MATRIX METALLOPROTEINASE (MMP)-9 AND TISSUE INHIBITOR OF MMPS (TIMP)-1 IN HYPERTENSION: A META-ANALYSIS: 4B.03 (2011) (1)
Oxidase-Derived Reactive Oxygen Species Independently of Blood Pressure Elevation ? Inflammation and Vascular Hypertrophy Induced by Angiotensin II : Role of NADPH (2003) (1)
Abstract P116: Induction of Human Endothelin-1 Overexpression for 3 Months Increases Plasma Aldosterone (2018) (1)
A Message From the New Editorial Team at the American Journal of Hypertension. (2016) (1)
Wednesday May 28, Ballroom C, 7:00 pm Effects of Hypertension, Aging, and Drugs on the Arterial Vasculature: The effects of antihypertensive drugs on the wall of small arteries (1997) (1)
Measurement of phospholipase d activation in vascular smooth muscle cells. (2001) (1)
Renin-Angiotensin Inhibitors and Vascular Effects (2004) (1)
P-203: H2O2 modulates calcium-dependent signaling pathways in vascular smooth muscle cells -alterations in SHR (2002) (1)
ARE CENTRAL HEMODYNAMIC PARAMETERS BETTER PROGNOSTIC MARKERS THAN PERIPHERAL BLOOD PRESSURE IN STROKE (2018) (1)
Biomarkers of prognosis in patients with post-acute-myocardial infarction heart failure: results of an EPHESUS sub-study (2004) (1)
P-338: Gender differences in blood pressure in estrogen-deficient FORKO mice (2002) (1)
Role of vascular endothelin in hypertension (2006) (1)
Definition & diagnosis of hypertension (2013) (1)
How are stressed prehypertensive rats pressured? Endothelin pleads guilty. (2010) (1)
Reply to letter by S. Bund regarding 'differential effects of vasopressin and endothelin-1 on vascular contractile and calcium responses in pressurized small arteries from SHR (1997) (1)
A2921 In vivo miR-431–5p knockdown protects against angiotensin II-induced hypertension and vascular injury (2018) (1)
Abstract P617: Angiotensin II-induced Hypertension And Vascular Injury Is Mediated By Gamma/delta T Cells (2015) (1)
Reply: no support for renal denervation in a meta-analysis. (2013) (1)
Angiotensin Type 2 Receptors in the Cardiovascular System (2007) (1)
PS-B12-3: ANGIOTENSIN II CAUSED ACTIVATED DNKT CELL EXPANSION IN MESENTERIC VESSEL PERIVASCULAR ADIPOSE TISSUE OF MALE MICE (2023) (0)
Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart (2003) (0)
ANGIOTENSIN II-INDUCED HYPERTENSION IS DEPENDENT ON FUNCTIONALLY ACTIVE C-SRCTYROSINE KINASE, BUT NOT FYN: OP 063 (2004) (0)
Corrigendum to: From the Editor-in-Chief: Issue at a Glance. (2022) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
Abstract 346: Subcutaneous Resistance Artery Remodeling And Function In Chronic Kidney Disease Patients (2014) (0)
Spontaneously Hypertensive Rats (2005) (0)
P-633: Role of the actin cytoskeleton in angiotensin II signaling in human vascular smooth muscle cells (2005) (0)
Essential role of src in angiotensin ii-mediated vascular smooth muscle ca2+ and contractile responses (2000) (0)
Chapter 14 – Remodeling of Resistance Arteries in Hypertension (2005) (0)
CHARACTERIZATION OF A NEW MURINE TRANSGENIC MODEL OF ENDOTHELIAL CELL HUMAN ENDOTHELIN-1 OVEREXPRESSION.4: P 062 (2004) (0)
CHRONOBIOLOGY OF BP 58 NIGHTTIME AMBULATORY PRESSURE PREDICTS RENAL DYSFUNCTION (2014) (0)
P-303: In vivo inhibition of ERK1/2-dependent signaling pathways improves vascular function in SHR (2001) (0)
Abstract P239: Angiotensin II-Induced Memory Gamma Delta T Cells Sensitize Mice To A Mild Hypertensive Stimulus (2022) (0)
P-541: Spironolactone improves vascular structure and endothelial function of resistance arteries in angiotensin II-infused rats (2002) (0)
EFFECTS OF SPIRONOLACTONE ON CARDIAC INFLAMMATION AND FIBROSIS IN ANGIOTENSIN II-INDUCED HYPERTENSION: OP 130 (2004) (0)
OR-24: Effects of aldosterone antagonism on structural and mechanical properties of small arteries altered by angiotensin II (2002) (0)
From the Editor-in-Chief: Issue at a Glance. (2022) (0)
A Systematic Review of the Long-Term Effects of Popular Diets on Weight Loss and Cardiovascular Risk Factors (2013) (0)
Abstract 118: P2X7 Receptor Contributes To Angiotensin II-induced Hypertension, Vascular Injury And Cd8 + T Cell Activation (2022) (0)
Abstract 131: Interleukin-23 Receptor Deficiency Increased Interferon-gamma Producing T Cells And Potentiated Blood Pressure Elevation In Angiotensin II-infused Mice (2022) (0)
Debate on the Objectives of Blood Pressure Lowering after the SPRINT Study (2017) (0)
P-189: Effect of PPAR-α activators docosahexaenoic acid and fenofibrate on myocardial inflammation and collagen deposition in angiotensin II-infused rats (2002) (0)
O-1: Increased expression of peroxisome proliferator-activated receptors (PPARS) in resistance arteries of spontaneously hypertensive rats (2001) (0)
Abstract 264: Erythropoietin-induced Hypertension and Vascular Injury in Mice Overexpressing Human Endothelin-1 Was Attenuated by Exercise (2012) (0)
OS 21-06 THREE-MONTH EXPOSURE TO ENDOTHELIN-1 OVEREXPRESSION INCREASES BLOOD PRESSURE AND CAUSES SMALL ARTERY INJURY. (2016) (0)
Regular exercise reduces adipose tissue inflammation and improves glycemic control in Western diet‐fed mice despite hyperendothelinemia (2018) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
ALDOSTERONE CONTRIBUTES TO SYSTOLIC BLOOD PRESSURE ELEVATION DURING REST TIME IN MALE MICE INDUCIBLY OVEREXPRESSING HUMAN ENDOTHELIN-1 IN ENDOTHELIUM (2021) (0)
OS 15-02 MATRIX METALLOPROTEINASE 2 KNOCKOUT PROTECTS FROM ANGIOTENSIN II-INDUCED VASCULAR INJURY IN PART VIA INHIBITION OF EGFR AND ERK1/2 ACTIVATION. (2016) (0)
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA INTERFERES WITH ANGIOTENSIN II SIGNALING IN BLOOD VESSELS: P 246 (2004) (0)
human endothelin-1 targeted to the endothelium Vascular gene expression in mice overexpressing (2015) (0)
New treatments for hypertension (2004) (0)
Fibrosis in Mineralocorticoid-Dependent Hypertension Activators Prevent Cardiac γ and Receptor-α Peroxisome Proliferator-Activated Receptor (2003) (0)
Implications of Atrial Natriuretic Factor (ANF) in the Pathogenesis of Experimental and Human Hypertension (1987) (0)
Src-Dependent Erk1/2-Mediated Signaling Pathways and Associated Ang Ii-Stimulated Growth Responses Are Altered in Vascular Smooth Muscle Cells from Arteries of Hypertensive Patients. (2000) (0)
Effect of Renal Disease in Patients With Established Heart Failure or Postmyocardial Infarction (2007) (0)
PS-B11-8: ONE NOVEL MIRNA WITH 4 MRNA TARGETS WAS IDENTIFIED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME (2023) (0)
Update From the Editors to Our Readers. (2017) (0)
SY 01-1 ADAPTATION OF MAJOR GUIDELINES FOR REGIONAL APPLICATIONS. (2016) (0)
Who is an expert? Reply (2017) (0)
Abstract P189: Human Endothelin-1 Overexpression in Mice Changed Gene Expression in Mesenteric Arteries (2019) (0)
Angiotensin II induced hyperplasia and hypertrophy in human vascular smooth muscle cells are mediated via AT1 receptors (1998) (0)
Abstract 311: Early Losartan Treatment Prevents the Developmental Programming of Cardiac Dysfunction Caused by Neonatal High Oxygen Exposure in Rats (2014) (0)
Abstract 485: Transglutaminase 2 is a Regulator of Angiotensin II-induced ERK1/2 Activation in Vascular Smooth Muscle Cells. (2012) (0)
S-40-3: MEMORY GAMMA DELTA T CELLS PLAY A ROLE IN HYPERTENSION (2023) (0)
O-40: Effect of dual inhibition of angiotensin converting enzyme and neutral endopeptidase on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats (2001) (0)
S-40-4: ANGIOTENSIN II-INDUCED BLOOD PRESSURE ELEVATION WAS POTENTIATED TOGETHER WITH INCREASES IN INTERFERON-GAMMA PRODUCING T CELLS IN INTERLEUKIN-23 RECEPTOR-DEFICIENT MICE (2023) (0)
Imbalance Underlies Endothelial Dysfunction in the Human Coronary Circulation Oxidative Stress , Nitric Oxide Synthase , and Superoxide Dismutase : A Matter of Print (2007) (0)
A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region: the spirit study (2018) (0)
DIFFERENTIALLY EXPRESSED MICRORNAS AND THEIR TARGETS WERE IDENTIFIED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH HYPERTENSION ASSOCIATED OR NOT WITH TARGET ORGAN DAMAGE (2021) (0)
Abstract MP44: A Novel And 2 Known Differentially Expressed MicroRNAs Were Identified In Peripheral Blood Mononuclear Cells Of Patients With Hypertension Associated With Metabolic Syndrome (2021) (0)
A029 Inhibition of mitogen-activated protein kinase attenuates and II-induced alkalinization and contraction in SHR vascular smooth muscle cells (1998) (0)
The Potential Role of Primary Care in Case Detection/Screening of Primary Aldosteronism. (2017) (0)
The Atrial Natriuretic Factor Purification, Isolation of the Peptide and of Prepro ANF, and Physiological Studies (1986) (0)
414 ERYTHROPOIETIN-INDUCED HYPERTENSION AND VASCULAR INJURY IN MICE OVEREXPRESSING HUMAN ENDOTHELIN-1 WAS ATTENUATED BY EXERCISE (2012) (0)
Chapter 28 – The Endothelin System (2007) (0)
Abstract 1626: Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Inflammatory Biomarkers in Hypertensive Patients (2007) (0)
Abstract 3750: Endothelial NO Synthase Uncoupling Impairs Formation and Induces Senescence of Endothelial Progenitor Cells in Mild Hyperhomocysteinemic Mice (2008) (0)
Abstract 345: Role Of Vascular Smooth Muscle Cell PPARγ In Aldosterone-induced Vascular Injury (2014) (0)
C020 Differential effects of pressurization on mechanical properties in small arteries from uninephrectomized and doca-salt rats (1998) (0)
SY 01-1 ADAPTATION OF MAJOR GUIDELINES FOR REGIONAL APPLICATIONS. (2016) (0)
Interleukin-2 Enhances Angiogenesis and Preserves Cardiac Function Following Myocardial infarction (2010) (0)
Abstract 12: The Role Of Memory Gamma Delta T Cells In Hypertension And Vascular Damage (2021) (0)
F012: Antioxidant treatment reverses vascular remodeling, but not myogenic tone in mesenteric resistance arteries of stroke-prone spontaneously hypertensive rats (SHRSP) (2000) (0)
Abstract 185: Transient Neonatal High Oxygen Exposure Leads to Cardiac Dysfunction and Renin Angiotensin System Activation in Rats (2013) (0)
EPLERENONE PREVENTS CARDIAC AND VASCULAR REMODELING AND IMPROVES RENAL FUNCTION IN SALT-DEPENDENT HYPERTENSION: P 225 (2004) (0)
Expression of Cell Cycle Proteins P21waf1/Cip1, P27kip1, Cyclin D1 and CDK4 in Blood Vessels of Angiotensin II-Infused Rats. Role of AT1 Receptors. (2000) (0)
Abstract 6269: Weight Loss Pharmacotherapies: Are Treatment Effects Maintained between 6 and 12 Months? (2008) (0)
Oxidative stress in arterial hypertension and atherosclerosis (2011) (0)
A3978 miR-338–3p down-regulation was identified in small arteries of hypertensive patients with chronic kidney disease (2018) (0)
Abstract 344: Endothelin-1 Overexpression Exaggerates Diabetes-induced Endothelial Dysfunction (2014) (0)
Atrial Natriuretic Peptide Inhibits Angiotensin II, ACTH, and Potassium Stimulated Calcium Influx by Isolated Rat Adrenal Glomerulosa Cells (1986) (0)
Are effects due to inhibition of the local renin-angiotensin system? (2000) (0)
Hypertension and oxidant stress (2004) (0)
INTROGRESSION OF A BROWN NORWAY CHROMOSOME 2 FRAGMENT INTO DAHL SALT-SENSITIVE RATS EXERTS ANTI- AND PRO-INFLAMMATORY EFFECTS UNDER A NORMAL AND HIGH-SALT DIET, RESPECTIVELY (2021) (0)
Abstract 083: γ/δ T Cells Play a Role in Development of Hypertension (2016) (0)
Abstract 13: P2X7 Receptor Knockout Attenuates Angiotensin II-Induced Hypertension, Vascular Injury And CD8 + T Cell Infiltration (2021) (0)
Abstract 167: Mapping of Chromosome 2 Regions Linked to Vascular Inflammation Using Congenic Rats (2012) (0)
Vessels of Spontaneously Hypertensive Rats in Blood γ and-α Increased Expression of Peroxisome Proliferator-Activated Receptor (2001) (0)
B1 Effect of chronic treatment with two different ETA-selective endothelin receptor antagonists on blood pressure and small artery structure of docasalt hypertensive rats (1997) (0)
A novel mouse model to characterize the mechanisms of endothelin-1-induced vascular injury (2013) (0)
MPS 01-01 A CONSERVED microRNA CLUSTER AS A POTENTIAL MASTER GENE EXPRESSION REGULATOR IN ANGIOTENSIN II-INDUCED VASCULAR DAMAGE (2016) (0)
[New treatments in hypertension: direct renin inhibitors]. (2008) (0)
Clinical trials report. CHARM-Overall Programme. (2004) (0)
c-Src regulates vascular inflammatory and fibrogenic but not growth signaling pathways in aldosterone-induced hypertension (2007) (0)
Transport in Vascular Smooth Muscle Cells in Genetic Hypertension 2 +-Dependent Mg + Stimulated Na − Exchanger Modulates Angiotensin II +-H + Activation of the Na Print (1999) (0)
ffect of Fibrates on Lipid Profiles and Cardiovascular utcomes : A Systematic Review (0)
Chapter 99 – Arterial Hypertension (2012) (0)
B005: Increased αvβ3 integrins in mesenteric resistance arteries from SHR: Effect of anti-hypertensive therapy (1999) (0)
A2877 ENDOTHELIN-1 EXAGGERATES TYPE-1 DIABETES-ACCELERATED ATHEROSCLEROSIS THROUGH NADPH OXIDASE 1 (2018) (0)
P-343: Aldosterone activates ERK1/2 and p38map kinase in vascular smooth muscle cells by nongenomic mechanisms in WKY and SHR – role of endothelin-1 (2004) (0)
Response to Are the Eutrophic Effects of Angiotensin Receptor Blockers Real (2006) (0)
SP 02-5 DO WE NEED A NEW DEFINITION OF HYPERTENSION? (2016) (0)
Antihypertensive drugs and events: Answers from INSIGHT and NORDIL (2001) (0)
Abstract 080: Endothelin-1 Exaggerates Type-1 Diabetes-Accelerated Atherosclerosis Through NADPH Oxidase 1 (2017) (0)
Chapter 69 – Endothelin Antagonists (2005) (0)
Abstract 1562: Increases of Immune Cells and their Related Cytokines in Blood and Spleen are Modulated by Chromosome 2 in Hypertensive Rats with an Activated Endothelin System (2008) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
From the Editor-in-Chief: Issue at a glance. (2021) (0)
From the Editor-in-Chief: Issue at a Glance. (2022) (0)
Abstract P3003: miR-338-3p Down-Regulation Caused Up-Regulation of Alkaline Ceramidase 2 and Glutathione Peroxidase 3 mRNAs in Subcutaneous Small Arteries of Hypertensive Patients With Chronic Kidney Disease (2019) (0)
Natriuretic Peptides as a Diagnostic and Therapeutic Tool in Cardiovascular Disease (2003) (0)
ANZSN Program at a Glance (2021) (0)
OS 21-01 NOX1 OR NOX4 DELETION PREVENTS TYPE 1 DIABETES-INDUCED ENDOTHELIAL DYSFUNCTION. (2016) (0)
Abstract P279: Mapping of Chromosome 2 Differentially Expressed Aortic Genes Linked to Vascular Inflammation Using Congenic Rats Fed a High-salt Diet (2017) (0)
[Renin-angiotensin system and the pathogenesis of arterial hypertension]. (1979) (0)
Abstract 343: Endothelin-1 Overexpression Preserves Endothelial Function In Mice With Vascular Smooth Muscle Cell-specific Deletion Of Ppar-gamma (2014) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
Abstract P062: Long-term Exposure to Endothelin-1 Overexpression Increases Blood Pressure and Causes Small Artery Injury (2015) (0)
Model of Menopause-Associated Hypertension Attenuated Responses to Angiotensin II in Follitropin Receptor Knockout Mice, a (2010) (0)
Participate Guanylate Cyclase: Target Enzyme for ANF (1986) (0)
In Memoriam Jacques Genest Sr, C.C., MD, MACP, FRCPC 1919–2018 (2018) (0)
OR-22: Src is an upstream regulator of NADPH oxidase in human vascular smooth muscle cells (2002) (0)
A3964 Identification of chromosome 2 differentially expressed aortic genes linked to vascular inflammation using congenic rats fed a normal and high-salt diet (2018) (0)
Vascular remodeling and endothelin antagonism in hypertension (1995) (0)
Response to Aldosterone and Large Arteries (2006) (0)
Abstract P601: Matrix Metalloproteinase 2 Plays An Important Role In Angiotensin Ii-induced Vascular Injury Mediated In Part Through Epidermal Growth Factor Receptor Activation In Vascular Smooth Muscle Cells (2015) (0)
Estrogen receptors and T cells determine how sex affects aldosterone-induced hypertension. (2020) (0)
President ’ s Report 1999-2000 Buy-in from Patients , Health Care Community is Required for Future Progress Hypertension (2001) (0)
Abstract P316: ANGIOTENSIN II-INDUCED LEFT VENTRICLE HYPERTROPHY AND DYSFUNCTION WERE EXAGGERATED BY P2RX7 KNOCKOUT BUT UNAFFECTED BY P2RX7 PHARMACOLOGIC BLOCKADE (2022) (0)
Abstract P283: Gamma Delta T Cells Drive CD4 + and CD8 + T Cell Activation in Hypertension (2018) (0)
Abstract 008: Aldosterone Contributes to the Blood Pressure Elevation, Endothelial Dysfunction, and Norepinephrine Sensitivity Caused by Endothelial Human Endothelin-1 Overexpression in Mice (2019) (0)
MPS 18-08 MAPPING OF CHROMOSOME 2 REGIONS LINKED TO VASCULAR INFLAMMATION USING CONGENIC RATS (2016) (0)
GAMMA-DELTA T CELLS MEDIATE ALPHA-BETA T CELL ACTIVATION IN ANGIOTENSIN II-INDUCED HYPERTENSION (2021) (0)
Abstract 375: A New Mouse Model to Characterize the Mechanisms of Endothelin-1-Induced Vascular Injury (2013) (0)
COMBINED TREATMENT WITH LOW DOSES OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AND GAMMA ACTIVATORS REDUCES BLOOD PRESSURE, AND PREVENTS REMODELING AND INFLAMMATION OF MESENTERIC RESISTANCE ARTERIES IN ANGIOTENSIN H-INFUSED RATS: OP 073 (2004) (0)
Effect of Antihypertensive Treatment on Structure and Function of Resistance Arteries in Essential Hypertensive Patients (1994) (0)
MIR-338-3P DOWN-REGULATION IN SMALL ARTERIES OF HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE MAY ACT VIA UP-REGULATION OF ALKALINE CERAMIDASE 2 AND GLUTATHIONE PEROXIDASE 3 (2021) (0)
Vascular injury, vascular healing, hypertension and the renin system (2000) (0)
New hypertension guidelines published by ASH/ISH (2014) (0)
Immune Mechanisms in Vascular Remodeling in Hypertension (2020) (0)
OS 21-06 THREE-MONTH EXPOSURE TO ENDOTHELIN-1 OVEREXPRESSION INCREASES BLOOD PRESSURE AND CAUSES SMALL ARTERY INJURY (2016) (0)
S-40-1: INFLAMMATION AND IMMUNITY IN HYPERTENSION (2023) (0)
Adrenal Steroids in Hypertension Hypertension caused by overproduction of mineralocorticoid hormones (0)
Abstract P151: Short- and Long-Term Induction of Human Endothelin-1 Overexpression in Mice Up-Regulated the Expression of Khdrbs3 in Mesenteric Arteries (2018) (0)
From the Editor-in-Chief: Issue at a Glance. (2022) (0)
Angiotensin II activation of Src mediates ERK stimulation in human vascular smooth muscle cells (1999) (0)
RECOMBINANT HUMAN ERYTHROPOIETIN ALTERS SUBCUTANEOUS RESISTANCE ARTERY ENDOTHELIAL FUNCTION THROUGH A MECHANISM INVOLVING OXIDATIVE STRESS AND ENDOTHELIN-1 IN PATIENTS WITH STAGE 4 CHRONIC KIDNEY DISEASE: 1C.07 (2011) (0)
ASH XII abstractThe effects of antihypertensive drugs on the wall of small arteries (1997) (0)
B004: Upregulation of src plays an important role in altered vascular function in genetic hypertension (2000) (0)
Patients Angiotensin Type 2 Receptor in Resistance Arteries of Type 2 Diabetic Hypertensive (2007) (0)
ANGIOTENSIN II-INDUCED AT2 STIMULATION NEGATIVELY MODULATES RHO KINASE-DEPENDENT PHOSPHORYLATION OF MYOSIN LIGHT CHAIN IN VASCULAR SMOOTH MUSCLE CELLS AND PROMOTES VASORELAXATION IN SHRSP RESISTANCE ARTERIES: OP 076 (2004) (0)
Measurement of intracellular free calcium ion concentration in vascular smooth muscle cells : fluorescence imaging of cytosolic calcium. (2000) (0)
Abstract 11265: Sex-Specific Response to Endothelin-1 Overexpression Mediates Thoracic Aortic Aneurysm Development (2021) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
Induced Apoptosis by Inhibition of Caspase 3 − 3 Fatty Acid ω Endothelin-1 Attenuates (2000) (0)
B003: Pld-dependent generation of oxygen species is increased in ang ii-stimulated vascular smooth muscle cells from hypertensive patients (2000) (0)
Good news for patients with type 2 diabetes: angiotensin receptor blocker treatment delays progression of diabetic nephropathy (2002) (0)
MPS 18-02 ENDOTHELIN-1 OVEREXPRESSION PRESERVES ENDOTHELIAL FUNCTION IN MICE WITH VASCULAR SMOOTH MUSCLE CELL-SPECIFIC DELETION OF PPAR-GAMMA (2016) (0)
Abstract P625: Non-coding Rna Regulation Of Gene Expression In Angiotensin Ii-induced Vascular Damage (2015) (0)
Abstract 519: Endothelin-1-Induced Oxidative Stress and Inflammatory Cell Infiltration Play a Role in High-Fat Diet Induced-Atherosclerosis in Apolipoprotein E Knockout Mice (2012) (0)
Callera et al Endothelin and Oxidative Stress in DOCA-Salt Rats 813 (2003) (0)
PS-BPB04-2: P2RX7 DEFICIENCY OR P2RX7 ANTAGONISM BLUNTS ANGIOTENSIN II-INDUCED HYPERTENSION, VASCULAR INJURY AND CD8+ T CELL ACTIVATION (2023) (0)
Stroke-Prone Spontaneously Hypertensive Rats Eplerenone Prevents Salt-Induced Vascular Remodeling and Cardiac Fibrosis in (2004) (0)
Abstract 023: γδ T Cells Mediate αβ T Cell Activation in Angiotensin II-Induced Hypertension (2019) (0)
SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS. (2016) (0)
Improved Renal Function by Eta Receptor Blockade Is Associated with Reduced Renal Expression of Tgfβ and B FGF and Increased Activity of Mmp-2 in Shrsp (2000) (0)
NORDIL study (2001) (0)
Abstract 050: Endothelin-1 Overexpression In Endothelial Cells Increases Blood Pressure In An Endothelin Type A Receptor-Dependent Manner (2014) (0)
Abstract P150: Genes of a Brown Norway Chromosome 2 Fragment Introgressed Into Hypertensive Dahl Salt-Sensitive Background Exert Pro-Inflammatory Effects When Stimulated by a High-Salt Diet (2019) (0)
Abstract 43: A Functional Angiotensin Type 1a Receptor Is Required for Aldosterone to Induce Small Artery Endothelial Dysfunction, Inflammation and Oxidative Stress (2012) (0)
Retinal Alterations in Mice With Endothelium-Restricted Overexpression of Endothelin-1 (2007) (0)
10.14 Peroxisome Proliferator-Activated Receptors Activator, Rosiglitazone, Improves Vascular Structure and Reduces Lipid Deposition in Atherosclerotic Mthfr Knock-Out Mice (2007) (0)
A3952 Circulating miR-26a-5p and let-7g-5p are potential biomarkers of chronic kidney disease (2018) (0)
Usefulness of the Aldosterone-to-Renin Ratio for Screening Primary Aldosteronism Diastolic Dysfunction in Hypertensive Heart Disease (2003) (0)
A027 Modulation of structural remodeling and endothelin-1 expression in small mesenteric arteries by vasopressin in the doca-salt rat (1998) (0)
Ang II-induced proto-oncogene expression is altered in vascular smooth muscle cells from essential hypertensive patients — implications in vascular remodeling. (1999) (0)
7th Int. Symposium on Resistance Arteries (2004) (0)
[ANF receptors at the glomerular level in reno-vascular hypertension in rats]. (1987) (0)
Abstract 098: Foxp3+ T Regulatory Lymphocytes Counteract Angiotensin Ii-induced Vascular Injury (2013) (0)
16 ENDOTHELIN-1-INDUCED OXIDATIVE STRESS AND INFLAMMATORY CELL INFILTRATION ARE ASSOCIATED WITH DEVELOPMENT OF ANEURYSMS IN HIGH-FAT DIET-FED APOLIPOPROTEIN E KNOCKOUT MICE (2012) (0)
A030: Angiotensin II-activated map kinase pathways are associated with sustained vascular smooth muscle contraction (1998) (0)
P-286: Effect of ETA receptor antagonist and aldosterone antagonist on blood pressure and vascular remodeling in aldosterone-infused rats (2002) (0)
Endothelin-1-induced oxidative stress and inflammatory cell infiltration contribute to high-fat diet induced-atherosclerosis and aneurysm formation in apolipoprotein E knockout mice (2013) (0)
Effect of treatment on cardiac small resistance arteries in hypertension and diabetes: trick or treat. (2012) (0)
B005: Pi3 kinase regulates ang ii-stimulated erk activity in vascular smooth muscle cells from shr (2000) (0)
Humoral factors and blood pressure in DOCA-salt hypertensive rats. (1997) (0)
PPAR&agr; Activator Effects on Ang II–Induced Vascular Oxidative Stress and Inflammation (2002) (0)
10.13 Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients (2007) (0)
AJH Peer Review 2015. (2016) (0)
[Receptors for vasoactive peptides in experimental hypertension and cardiac insufficiency]. (1988) (0)
Interactions of Angiotensin II and Atrial Natriuretic Peptide (2018) (0)
PS 16-31 ENDOTHELIN-1 EXAGGERATES TYPE-1 DIABETES-ACCELERATED ATHEROSCLEROSIS THROUGH NADPH OXIDASES 1 AND 4 (2016) (0)
Vascular remodeling action of angiotensin II from bench to bedside (2000) (0)
Smooth Muscle Cells From Spontaneously Hypertensive Rats Transactivation Is Associated With Decreased C-Terminal Src Kinase Activity in Vascular Increased Angiotensin II-Mediated Src Signaling via Epidermal Growth Factor Receptor (2002) (0)
P-643: Resistance arteries of Ang II-infused osteopetrotic mice show reduced impairment of endothelial function, oxidative stress, and vascular remodeling: Role of inflammation and mCSF in hypertension (2005) (0)
Augmented ang II-stimulated vascular growth in human hypertension—role of ERK1/2 mediated c-fos-dependent signaling pathways (2000) (0)
Plasma Endothelin of Sibpairs: Variability, Inheritance, and Linkage to Obesity in Essential Hypertension (2000) (0)
60 IMMUNE MECHANISMS IN HYPERTENSION (2012) (0)
PS 07-16 CROSSTALK BETWEEN ALDOSTERONE-STIMULATED MINERALOCORTICOID RECEPTOR AND ANGIOTENSIN RECEPTOR PATHWAYS PLAYS A ROLE IN ALDOSTERONE-INDUCED VASCULAR INJURY (2016) (0)
OS 15-02 MATRIX METALLOPROTEINASE 2 KNOCKOUT PROTECTS FROM ANGIOTENSIN II-INDUCED VASCULAR INJURY IN PART VIA INHIBITION OF EGFR AND ERK1/2 ACTIVATION (2016) (0)
Abstract P1113: P2x7 Receptor Plays a Role in Angiotensin II-Induced Hypertension and Vascular Remodeling (2019) (0)
PROCEEDINGS OF THE 11TH INTERNATIONAL WORKSHOP ON STRUCTURE AND FUNCTION OF THE VASCULAR SYSTEM, 8–10 FEBRUARY 2018 IN PARIS, FRANCE (2018) (0)
Importancia en la hipertensión de péptidos recién identificados: endotelina, péptidos natriuréticos, adrenomedulina, leptina (2004) (0)
VARIANT GAMMA 6+ GAMMA-DELTA T CELLS PLAY A ROLE IN ANGIOTENSIN II-INDUCED HYPERTENSION (2021) (0)
Abstract 449: Develoment of Endothelin-1 Induced Aneurysms in High-Fat Diet-Fed Apolipoprotein E Knockout Mice Through a Mechanism Involving Oxidative Stress and Inflammatory Cell Infiltration (2012) (0)
Abstract 16: Adoptive Transfer of T Lymphocytes Prevents Angiotensin II-induced Vascular Stiffness in rag-1 Knockout Mice. (2012) (0)
Abstract P035: Endothelin-1 Overexpression Preserves Endothelial Function in Mice with Vascular Smooth Muscle Cell-specific Deletion of Ppar-gamma (2015) (0)
Effect of Vasopeptidase Inhibition on Myocardial and Vascular Collagen in Stroke Prone Spontaneously Hypertensive Rats. (2000) (0)
From the Editor-in-Chief: Issue at a Glance. (2022) (0)
Thursday, may 18, marquis ballroom, 6:30 am to 8:00 am. understanding the role of angiotensin ii in hypertension and beyond: The evidence for actions of angiotensin II on vascular growth (2000) (0)
Abstract P278: Identification of Differentially Expressed Aortic Genes in Brown Norway Introgressed Chromosome 2 Segments into Hypertensive Dahl Salt Sensitive Rats (2017) (0)
SP 02-5 DO WE NEED A NEW DEFINITION OF HYPERTENSION? (2016) (0)
Abstract MP60: Down-regulated Mir-338-3p In Subcutaneous Small Arteries Of Hypertensive Patients With Chronic Kidney Disease Targets Protein Tyrosine Phosphatase Receptor Type S And Glutathione Peroxidase 3 (2021) (0)
Abstract 126: Role of V γ6 + γδ T Cells in Angiotensin Il-Induced Hypertension and Vascular Injury (2019) (0)
EFFECT OF HEMODIALYSIS ON LARGE ARTERIES IN PATIENTS WITH INTRADIALYTIC HYPERTENSION: 5C.07 (2011) (0)
Hypertension, brain imaging phenotypes, and cognitive impairment: lessons from Mendelian randomization. (2023) (0)
Altered resistance artery wall composition in SHR: normalization by irbesartan. (1999) (0)
News from Hypertension Societies: News from the Inter-American Society of Hypertension (1992) (0)
Nad(p)h Oxidase Regulates Cyclin D1 and Cdk4 but not P21Cip1 and P27Kip1 - Role in Ang Ii-mediated Growth of Human Vsmcs: P48 (2005) (0)
Intracellular Signaling Pathways and Peroxisome Proliferator-Activated Receptors in Vascular Health in Hypertension and in Diabetes (2007) (0)
Hypertension: Methods and Protocols (2017) (0)
Abstract 60: Reduced Macrophage-dependent Inflammation Improves Endothelial Function and Vascular Remodeling, Oxidative Stress and Inflammation in a Model Of Endothelin-1 Induced Vascular Injury (2012) (0)
Abstract 300: Targeted Deletion of Matrix Metalloproteinase 2 Prevents Angiotensin II-Induced Endothelial Dysfunction and Vascular Remodeling, Oxidative Stress and Inflammation (2013) (0)
PS-BPB02-4: LEFT VENTRICLE HYPERTROPHY AND DYSFUNCTION WERE EXAGGERATED BY P2RX7 KNOCKOUT BUT UNAFFECTED BY P2RX7 PHARMACOLOGIC BLOCKADE IN ANGIOTENSIN II-INFUSED MICE (2023) (0)
S-16-1: RESISTANT HYPERTENISION: CLINICAL CHARACTERISTICS AND BLOOD PRESSURE CONTROL (2023) (0)
Abstract 406: Improved Angiotensin II Type 2 Receptor Expression and Function in Transglutaminase 2 Knock-Out Mice Treated with Angiotensin II (2013) (0)
Abstract P223: Identification of Chromosome 2 Differentially Expressed Genes Linked to Vascular Inflammation Using Congenic Rats Fed a Normal and High-Salt Diet (2018) (0)
Mineralocorticoid receptor on T cells contributes to injury and remodeling of ischemic myocardium. (2023) (0)
SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS. (2016) (0)
ENDOTHELIN-1 REGULATES MAP KINASES THROUGH MITOCHONDRIAL-DERIVED REACTIVE OXYGEN SPECIES, WHEREAS ANGIOTENSIN II EFFECTS ARE MEDIATED VIA NADPH OXIDASE-DERIVED SUPEROXIDE IN HUMAN VASCULAR SMOOTH MUSCLE CELLS: OP 104 (2004) (0)
Effect of irbesartan on structure and mechanical properties of small arteries from the spontaneously hypertensive rat (1998) (0)
ON RESISTANCE ARTERIES New Developments in Resistance Artery Research : From Molecular Biology to Bedside Peroxisome proliferator-activated receptors and cardiovascular remodeling (2005) (0)
Abstract 257: Mapping of Chromosome 2 Regions Linked to Vascular Inflammation using Congenic Rats (2012) (0)
LOWER CIRCULATING MIR-191-5P AND LET-7G-5P ARE INDEPENDENT BIOMARKERS OF RENAL INJURY (2021) (0)
Abstract P034: Endothelin-1 Overexpression Exaggerates Diabetes-induced Endothelial Dysfunction by Altering Oxidative Stress Balance (2015) (0)
Author Index to Abstracts (1998) (0)
10th Annual Meeting of the European Renal Cell Study Group (1998) (0)
Vascular Remodeling in Hypertension and Metabolic Syndrome (2010) (0)
ANGIOTENSIN II-INDUCED TRANSGLUTAMINASE 2 REGULATES P-38 MAP-KINASE LONG TERM EXPRESSION IN SHR VASCULAR SMOOTH MUSCLE CELLS: 2C.02 (2010) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
Erythropoietin induced blood pressure rise, vascular inflammation and oxidative stress in mice overexpressing human endothelin-1: Improvement by exercise (2013) (0)
Abstract 070: ONE UP-REGULATED NOVEL MICRORNA AND 4 DOWN-REGULATED MRNA TARGETS WERE IDENTIFIED IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME (2022) (0)
Increased Generation of Vascular Reactive Oxygen Species by Ang II Is Mediated Via Src-Dependent Pathways in Essential Hypertension. (2000) (0)
Antioxidant vitamins inhibit progression of hypertension and improve endothelial dysfunction and antioxidant status in SHRSP (2000) (0)
Abstract P158: MicroRNA Profiling in Peripheral Blood Mononuclear Cells From Hypertensive Patients With or Without Chronic Kidney Disease (2017) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
From the Editor-in-Chief: Issue at a Glance. (2021) (0)
Abstract P317: ANGIOTENSIN II INFUSION CAUSED EXPANSION OF ACTIVATED ð NATURAL KILLER T CELLS IN MESENTERIC VESSEL PERIVASCULAR ADIPOSE TISSUE OF MICE (2022) (0)

This paper list is powered by the following services:

Other Resources About Ernesto Schiffrin

en.wikipedia.org

What Schools Are Affiliated With Ernesto Schiffrin?

Ernesto Schiffrin is affiliated with the following schools: